Clio Infotech Board Approves Allotment of 2,17,50,000 Convertible Warrants, Authorises Rs.100 Crores Investment Limit

The Board of Directors of Clio Infotech Limited convened a meeting on Wednesday, 13th May, 2026, at its registered office in Ahmedabad, Gujarat. The meeting, which commenced at 1:30 P.M. and concluded at 2:00 P.M., resulted in several significant corporate decisions disclosed pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Allotment of Convertible Warrants on Preferential Basis

The board approved the allotment of 2,17,50,000 (Two Crore Seventeen Lakhs Fifty Thousand) convertible warrants to entities belonging to the 'Non-Promoter' category on a preferential basis. The allotment was made in accordance with the provisions of Chapter V of SEBI (ICDR) Regulations, 2018, at a price re-computed as per the applicable regulatory framework. The details of the allottee are as follows:

Parameter: Details Allottee Name: Falcon Peak Fund (CEIC) LTD No. of Convertible Warrants Allotted: 2,17,50,000 Consideration (Amount in Rs.): 5,43,75,000 Face Value per Equity Share: Re. 10.00/- Conversion Period: 18 months from date of allotment Balance Consideration Before Conversion: 75% of the Issue price per Warrant Category: Non-Promoter

Each warrant entitles the holder to exercise the option to convert and receive one fully paid-up equity share of face value Re. 10.00/- against each warrant within 18 months from the date of allotment. The balance consideration, being 75% of the issue price per warrant, is payable before the exercise of the conversion option. The new equity shares issued upon conversion shall rank pari-passu with the existing equity shares of the Company.

Ratification of Warrant Issuance Resolution

The board also considered and approved the ratification of the resolution pertaining to the issue of warrants convertible into equity shares to entities in the 'Non-Promoter' category on a preferential basis. This ratification was necessitated due to the re-computation of the price of equity shares to be issued upon conversion of warrants. The original resolution had been passed by shareholders at the Annual General Meeting held on 12th September, 2025.

Investment and Financial Authorisation

Pursuant to Section 186 of the Companies Act, 2013, the board approved an authorisation to make loans, give guarantees, provide securities, and/or make investments up to an overall limit of Rs.100 Crores. This authorisation is subject to the approval of shareholders.

Scrutinizer Appointment and Postal Ballot

The board took the following additional decisions to facilitate the postal ballot process:

Appointment of Scrutinizer: Ms. Shubhangi Agarwal (Membership No. A63219, COP No. C.P.NO. 23802), Practicing Company Secretary, was appointed as Scrutinizer to conduct the voting process in a fair and transparent manner.

Postal Ballot Notice: The board approved the issuance of the notice of Postal Ballot.

The disclosures were signed by Managing Director Nikita Tiwadi (DIN: 10646772) on behalf of Clio Infotech Limited.

Clio Infotech has notified the BSE Limited of an upcoming board meeting scheduled for Monday, May 18, 2026, pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was issued on May 11, 2026, and signed by Ms. Nikita Tiwadi, Managing Director of the company.

Board Meeting Agenda

The board meeting has been convened to address key regulatory and financial matters. The following items are on the agenda:

Consideration, approval, and taking on record of the Audited Financial Results for the quarter and year ended March 31, 2026, as required under Regulation 33 of SEBI (LODR) Regulations, 2015.

Discussion and consideration of any other items as may be decided by the Board of Directors.

The table below summarises the key details of the scheduled board meeting:

Parameter: Details Meeting Date: Monday, May 18, 2026 Intimation Date: May 11, 2026 Regulatory Reference: Regulation 29(1), SEBI (LODR) Regulations, 2015 Financial Results Period: Quarter and year ended March 31, 2026 Applicable Regulation for Results: Regulation 33, SEBI (LODR) Regulations, 2015 Signatory: Ms. Nikita Tiwadi, Managing Director (DIN: 10646772)

Trading Window Closure

In accordance with the company's Code of Conduct for Prohibition of Insider Trading, the trading window has been closed effective April 1, 2026. The closure will remain in effect until the completion of 48 hours following the public declaration of the audited financial results for the quarter ended March 31, 2026. This restriction applies to all Directors, Key Managerial Personnel (KMPs), Designated Employees, and Connected Persons of the company as defined under the Code.

The intimation has been submitted to the Listing Department of BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.